| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 74, 963-967, Copyright © 1992 by Endocrine Society
ARTICLES |
S Ulick, JZ Wang, JD Blumenfeld and TG Pickering
Veterans Affairs Hospital, Bronx, New York 10468.
The more severe mineralocorticoid manifestations in the ectopic ACTH syndrome compared to pituitary Cushing's disease have been attributed to hypersecretion of 11-deoxycorticosterone. Another difference between the two forms of ACTH-excess, however, is a more severe degree of hypercortisolism in the ectopic syndrome. Cortisol can become a potent mineralocorticoid if its peripheral metabolism is interfered with as occurs in the syndrome of apparent mineralocorticoid excess. This mechanism also occurs in an experimental model of the apparent mineralocorticoid excess syndrome induced by licorice derivatives. We have tested the hypothesis that cortisol is a major mineralocorticoid in the ectopic ACTH syndrome because of two factors, marked hypersecretion and incomplete peripheral metabolism of cortisol as a result of an overload of metabolizing enzymes. Two measures of the peripheral metabolism of cortisol were found to be markedly decreased in two patients with the ectopic ACTH syndrome. The cortisol turnover quotients were 17.2 and 19.6 (normal = 215 +/- 98) and the ring A reduction constants were 11.8 and 13.8 (normal = 101 +/- 23). These values were comparable to that found in the syndrome of apparent mineralocorticoid excess and consistent with the hypothesis that cortisol is a significant functioning mineralocorticoid in the ectopic ACTH syndrome.
This article has been cited by other articles:
![]() |
G. Arnaldi, T. Mancini, B. Kola, G. Appolloni, S. Freddi, C. Concettoni, I. Bearzi, A. Masini, M. Boscaro, and F. Mantero Cyclical Cushing's Syndrome in a Patient with a Bronchial Neuroendocrine Tumor (Typical Carcinoid) Expressing Ghrelin and Growth Hormone Secretagogue Receptors J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5834 - 5840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Quinkler and P. M. Stewart Hypertension and the Cortisol-Cortisone Shuttle J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2384 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. TORPY, N. MULLEN, I. ILIAS, and L. K. NIEMAN Association of Hypertension and Hypokalemia with Cushing's Syndrome Caused by Ectopic ACTH Secretion: A Series of 58 Cases Ann. N.Y. Acad. Sci., September 1, 2002; 970(1): 134 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Heilmann, E. Buchheim, J. Wacker, and R. Ziegler Alteration of the Activity of the 11{beta}-Hydroxysteroid Dehydrogenase in Pregnancy: Relevance for the Development of Pregnancy-Induced Hypertension? J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5222 - 5226. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Phillipov Defective Cortisone 11-Oxoreductase Activity? J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1425b - 1426. [Full Text] |
||||
![]() |
B. Weber, S. Lewicka, M. Deuschle, M. Colla, P. Vecsei, and I. Heuser Increased Diurnal Plasma Concentrations of Cortisone in Depressed Patients J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1133 - 1136. [Abstract] [Full Text] |
||||
![]() |
G. Morineau, A. Boudi, A. Barka, M. Gourmelen, F. Degeilh, N. Hardy, A. Al-Halnak, H. Soliman, J. P. Gosling, R. Julien, et al. Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol–cortisone shuttle Clin. Chem., August 1, 1997; 43(8): 1397 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimojo, M. L. Ricketts, M. D. Petrelli, P. Moradi, G. D. Johnson, A. R. Bradwell, M. Hewison, A. J. Howie, and P. M. Stewart Immunodetection of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Mineralocorticoid Target Tissues: Evidence for Nuclear Localization Endocrinology, March 1, 1997; 138(3): 1305 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text] |
||||
![]() |
C.-L. Lin, T.-J. Wu, D. A. Machacek, N.-S. Jiang, and P. C. Kao Urinary Free Cortisol and Cortisone Determined by High Performance Liquid Chromatography in the Diagnosis of Cushing's Syndrome J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 151 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goto, K. Yamada, H. Hazama, Y. Uehara, K. Atarashi, Y. Hirata, K. Kimura, and M. Omata Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome Hypertension, September 1, 1996; 28(3): 421 - 425. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |